Gentron products will represent unique and novel approaches to cancer diagnosis and treatment.

The unique nature of this approach could potentially be used in many other clinical applications , such as allergies and rheumatology.

The large and growing demand for early cancer detection will expand the market and its current revenue streams.

Gentron's safe, well-tolerated and cost-effective solutions will be available for numerous clinical situations within the current paradigm.

Gentron’s approach represents a platform technology that will contribute to the earlier detection of disease, thereby improving human health-related condtions.

Intellectual Property and technology developed by Gentron are protected by Patents filed at the US Patent and Trademark Office under the Patent Cooperation Treaty.